Aptevo Therapeutics Shares Gain After First Dosed Patient in AML Trial Shows 90% Reduction in Leukemic Blasts
Aptevo Therapeutics Shares Gain After First Dosed Patient in AML Trial Shows 90% Reduction in Leukemic Blasts
aptevo therapeutics股票上漲，AML試驗中首位接受劑量的患者顯示白血病幼稚細胞減少90%
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間